MedTrace Logo

Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey

NCT04770129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1331

Last updated 2023-01-20

No results posted yet for this study

Summary

This study is planned as a secondary data use (SDU) study and the data collection will be performed retrospectively. Patients who presented to the participating sites with metastatic breast cancer will be defined, and patients' data will be recorded into a database.

Conditions

Sponsors & Collaborators

  • Acibadem Maslak Hospital

    collaborator OTHER

  • Ege University Hospital

    collaborator UNKNOWN

  • Marmara University Pendik Training and Research Hospital

    collaborator OTHER

  • Acibadem Altunizade Hospital, Istanbul

    collaborator UNKNOWN

  • Istanbul University

    collaborator OTHER

  • V.K.V. American Hospital, Istanbul

    collaborator OTHER

  • Hacettepe University, Faculty of Medicine

    collaborator UNKNOWN

  • Turkish Oncology Group

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-22
Primary Completion
2022-06-02
Completion
2022-08-08

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770129 on ClinicalTrials.gov